Clinical Trials Logo

Filter by:
NCT ID: NCT02391116 Completed - Clinical trials for Diffuse, Large B-Cell, Lymphoma

Phase II Copanlisib in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Start date: May 8, 2015
Phase: Phase 2
Study type: Interventional

To assess the potential efficacy (in terms of objective response) of single agent copanlisib in patients with relapsed or refractory Diffuse large B-cell lymphoma (DLBCL) and assess the relationship between efficacy and a potentially predictive biomarker

NCT ID: NCT02387307 Completed - Melanoma Clinical Trials

A Study of rSIFN-co in Subjects With Advanced Solid Tumors

rSIFN-01
Start date: July 2013
Phase: Phase 1
Study type: Interventional

This is a multicenter, open-label, phase I study of rSIFN-co (3 times a week via subcutaneous injection for 21 days, with 1 week of washout per cycle).

NCT ID: NCT02387242 Suspended - Tuberculosis Clinical Trials

Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Rifampicin in Healthy Volunteers

Start date: February 2015
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the bactericidal activity against Mycobacterium tuberculosis of standard and high doses of rifampicin. Pharmacokinetics (PK) and Whole blood Bactericidal Activity (WBA) will be measured in healthy volunteers following a single dose of rifampicin at standard dose (10mg/kg) or at high dose (20mg/kg or 30mg/kg).

NCT ID: NCT02381886 Active, not recruiting - Clinical trials for Advanced Malignancies That Harbor IDHR132 Mutations

A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations

Start date: March 6, 2015
Phase: Phase 1
Study type: Interventional

A Phase I study of IDH305 in patients with advanced malignancies that harbor IDH1R132 mutations.

NCT ID: NCT02381470 Completed - Clinical trials for Pulmonary Tuberculosis

Trial of Faropenem and Cefadroxil (in Combination With Amoxicillin/Clavulanic Acid and Standard TB Drugs) in Patients With Pulmonary Tuberculosis: Measurement of Early Bactericidal Activity and Effects on Novel Biomarkers

Start date: February 11, 2019
Phase: Phase 2
Study type: Interventional

This trial aims to determine whether the early bactericidal activity of rifampicin given with faropenem or cefadroxil (each given with amoxicillin/clavulanic acid) is greater than the activity of rifampicin alone in patients with pulmonary TB. The trial will also investigate potential new biomarkers of sterilising activity.

NCT ID: NCT02376907 Active, not recruiting - Jaundice Clinical Trials

Biliary Drainage in Patients With Duodenal Metal Stent

Start date: January 2010
Phase: N/A
Study type: Observational

This is a retrospective study to evaluate the outcomes of endoscopic biliary drainage according to the timing of distal malignant biliary obstruction (MBO) in relation to gastric outlet obstruction (GOO) and the location of GOO.

NCT ID: NCT02376725 Completed - Clinical trials for Glaucoma, Angle-closure

Comparing Phaco/IOL Versus Phaco/IOL + Goniosynechialysis in Subjects With PACG

Start date: June 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if phacoemulsification with intraocular lens implant (phaco/IOL) alone or combined with goniosynechialysis is better at controlling intraocular pressure in subjects with primary angle closure.

NCT ID: NCT02375958 Completed - Esophageal Cancer Clinical Trials

PCA062 in pCAD-positive Tumors.

Start date: April 15, 2015
Phase: Phase 1
Study type: Interventional

A first-in-human sttudy using PCA062 in patients with p-CAD positive solid tumors.

NCT ID: NCT02373709 Active, not recruiting - Clinical trials for Genetic Predisposition

Sequence Variations of Genes in the Estrogen Pathway and Perinatal Depression

Start date: October 2010
Phase:
Study type: Observational

To elucidate the disease pathway of perinatal depression by identifying genetic variants which could play a role in predisposing to the condition and/or lead to better understanding of the pathogenesis of the condition. This is achieved by investigating for associations between oestrogen receptor genetic variants and perinatal depression.

NCT ID: NCT02373696 Completed - Pain Clinical Trials

Chronic Pain Dynamic Psychophysical Tests and Genetic Screening

Start date: April 2010
Phase: N/A
Study type: Observational

Incidence and risk factors for persistent post surgical pain after Caesarean section are investigated. Demographic, psychophysical testing and genetic screening factors are performed in the perioperative period. Phone survey is performed to investigate the incidence of persistent post surgical pain after Caesarean section.